33 research outputs found

    Additional file 1: Table S1. of Is radiographic progression in modern rheumatoid arthritis trials still a robust outcome? Experience from tofacitinib clinical trials

    No full text
    Trimmed analysis of data for mTSS change from baseline at month 6 and month 12 in ORAL Scan and ORAL Start. The table provides least squares mean changes from baseline at month 6 and month 12, and treatment differences versus comparator with 95 % CIs for both the ORAL Scan and ORAL Start studies. (DOCX 15 kb

    Additional file 1 of Risk factors for non-participation in ivermectin and dihydroartemisinin-piperaquine mass drug administration for malaria control in the MASSIV trial

    No full text
    Additional file 1: Table S1. MDA coverage of individuals missing demographic data. Table S2. Interaction between age-groups and MDA status of household heads. Table S3. Interaction between sex and MDA status of household heads. Table S4. Factors associated with receiving at least one dose of ivermectin. Figure S1. Overall number of doses received for both DHP and IVM MDA for eligible participants. Figure S2. Overall number of doses received for both drugs for eligible participants including missing demographic data

    MOESM2 of Mosquito net coverage in years between mass distributions: a case study of Tanzania, 2013

    No full text
    Additional file 2. Tabulated data representing household ownership, access and use of LLINs by district in Tanzania, October–December 2013 also presented in Fig. 4. Definitions of mosquito net indicators are listed in Table 1

    MOESM1 of Mosquito net coverage in years between mass distributions: a case study of Tanzania, 2013

    No full text
    Additional file 1. Tabulated data representing household ownership, access and use of any nets, LLINs and UTNs by socio-economic quintile in Tanzania, October–December 2013 also presented in Fig. 3. Definitions of mosquito net indicators are listed in Table 1
    corecore